Flavoxate hydrochloride

Flavoxate hydrochloride, 3717-88-2, Flavoxate HCL, Urispas, Spasmal, DW-61, NSC-114649, DTXSID1047784, 9C05J6089W, 2-Piperidinoethyl 3-methyl-4-oxo-2-phenyl-4H-1-benzopyran-8-carboxylate hydrochloride, CHEBI:5089, DTXCID1027764, NSC114649, 4H-1-Benzopyran-8-carboxylic acid, 3-methyl-4-oxo-2-phenyl-, 2-(1-piperidinyl)ethyl ester, hydrochloride, Urispas 200, Hydrochloride, Flavoxate, RefChem:56749, DW 61, 2-(Piperidin-1-yl)ethyl 3-methyl-4-oxo-2-phenyl-4H-chromene-8-carboxylate monohydrochloride, 223-066-4, Bladderon, Peflate, Flavoxate (hydrochloride), DW 61 (flavoxate), 2-(piperidin-1-yl)ethyl 3-methyl-4-oxo-2-phenyl-4H-chromene-8-carboxylate hydrochloride, Rec 7/0040, Rec-7-0040, DW61, MFCD00072099, C24H26ClNO4, Piperidinoethyl-3-methylflavone-8-carboxylate hydrochloride, Spasuret hydrochloride, 2-piperidin-1-ylethyl 3-methyl-4-oxo-2-phenylchromene-8-carboxylate hydrochloride, Genurin, Spasuret, Urispadol, Verrispasmin amp., AK 123, NCGC00016636-01, CAS-3717-88-2, CCRIS 1950, SR-01000872667, UNII-9C05J6089W, Prestwick_884, EINECS 223-066-4, NSC 114649, REC 7-0040, Flavoxate hydrochloride [USAN:USP:JAN], Flavoxate hydrochloride CRS, MLS002154247, SCHEMBL124540, HY-B0549AR, orb1310369, CHEMBL1200875, SCHEMBL29395220, HY-B0549A, MSK11330A, XOEVKNFZUQEERE-UHFFFAOYSA-N, 1-Piperidinoethanol, hydrochloride, GLXC-06519, HMS1568B06, Flavoxate HCl - Bio-X trade mark, FLAVOXATE HYDROCHLORIDE [MI], Tox21_110537, EBC-12087, Flavoxate (hydrochloride) (Standard), Flavoxate hydrochloride (JP18/USP), FLAVOXATE HYDROCHLORIDE [JAN], s4027, FLAVOXATE HYDROCHLORIDE [USAN], AKOS025310107, Tox21_110537_1, AC-1093, CCG-220242, FF23299, FLAVOXATE HYDROCHLORIDE [MART.], 1-Piperidineethanol, 3-methyl-4-oxo-2-phenyl-4H-1-benzopyran-8-carboxylate, hydrochloride, FLAVOXATE HYDROCHLORIDE [USP-RS], FLAVOXATE HYDROCHLORIDE [WHO-DD], NCGC00016636-05, 3-Methyl-4-oxo-2-phenyl-4H-1-benzopyran-8-carboxylic acid 2-(1-piperidinyl)ethyl ester hydrochloride, 4H-1-Benzopyran-8-carboxylic acid, 3-methyl-4-oxo-2-phenyl-, 2-piperidinoethyl ester, hydrochloride, AS-12321, BF164464, SMR000499576, F0717, FLAVOXATE HYDROCHLORIDE [EP IMPURITY], FLAVOXATE HYDROCHLORIDE [ORANGE BOOK], NS00083275, SW197005-3, FLAVOXATE HYDROCHLORIDE [EP MONOGRAPH], D00718, D90684, EN300-123535, FLAVOXATE HYDROCHLORIDE [USP MONOGRAPH], Flavoxate hydrochloride, >=98% (HPLC), solid, F814885, SR-01000872667-1, Q27106648, WLN: T66 BO EVJ CR& D1 JVO2- AT6NTJ &GH, Z2768134941, 3-Methyl-4-oxo-2-phenyl-4H-1-benzopyran-8-carboxylic acid hydrochloride, 4H-1-Benzopyran-8-carboxylic acid, 2-piperidinoethyl ester, hydrochloride, Flavoxate hydrochloride, European Pharmacopoeia (EP) Reference Standard, Flavoxate hydrochloride, United States Pharmacopeia (USP) Reference Standard, 1-(2-{[(3-methyl-4-oxo-2-phenyl-4H-chromen-8-yl)carbonyl]oxy}ethyl)piperidinium chloride, 2-(1-piperidyl)ethyl 3-methyl-4-oxo-2-phenyl-chromene-8-carboxylate, hydrochloride, 2-(piperidin-1-yl)ethyl3-methyl-4-oxo-2-phenyl-4H-chromene-8-carboxylatehydrochloride, 2-Piperidinoethyl-3-methyl-4-oxo-2-phenyl-4H-1-benzopyran-8-carboxylate hydrochloride, 4H-1-Benzopyran-8-carboxylic acid, 2-(1-piperidinyl)ethyl ester, hydrochloride, 2-(Piperidin-1-yl)ethyl 3-methyl-4-oxo-2-phenyl-4H-1-benzopyran-8-carboxylate--hydrogen chloride (1/1)